SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2024 quarter moved down to Rs. 56391.40 millions as compared to Rs. 59482.20 millions during the year-ago period.The Total Profit for the quarter ended March 2024 of Rs. 8676.00 millions grew from Rs.-10208.20 millionsThe company reported a degrowth in operating Profit to 20124.10 millions from 24809.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 56391.40 59482.20 -5.20 202751.70 208121.40 -2.58 202751.70 208121.40 -2.58
Other Income 1188.80 1203.00 -1.18 5534.80 3292.90 68.08 5534.80 3292.90 68.08
PBIDT 20124.10 24809.50 -18.89 60533.70 67518.90 -10.35 60533.70 67518.90 -10.35
Interest 2175.90 1614.50 34.77 7840.80 4721.80 66.06 7840.80 4721.80 66.06
PBDT 17948.20 -6182.90 -390.29 50502.70 33419.20 51.12 50502.70 33419.20 51.12
Depreciation 3930.40 4119.80 -4.60 16006.20 16008.70 -0.02 16006.20 16008.70 -0.02
PBT 14017.80 -10302.70 -236.06 34496.50 17410.50 98.14 34496.50 17410.50 98.14
TAX 5341.80 -94.50 -5752.70 5914.70 503.30 1075.18 5914.70 503.30 1075.18
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 8676.00 -10208.20 -184.99 28581.80 16907.20 69.05 28581.80 16907.20 69.05
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 35.69 41.71 -14.44 29.86 32.44 -7.97 29.86 32.44 -7.97

Sun Pharma Inds. Share Price

1874.00 26.70 (1.45%)
11-May-2026 13:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.00
Dr. Reddys Lab 1294.85
Cipla 1322.00
Zydus Lifesciences 948.00
Lupin 2277.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×